Circulation 76,548 • Volume 20, No. 4 •
Winter 2005
Issue PDF
The following report highlights patient and family perspectives of adverse events that were presented at the APSF Board of Directors Workshop on October 21, 2005. These unique and important accounts…
As President of the Anesthesia Patient Safety Foundation (APSF), it is my privilege to report annually on the activities of the foundation during the past calendar year. I am pleased…
At its October 2005 annual meeting, the APSF was pleased to announce the appointment of Paul Baumgart as its new Vice President. Paul Baumgart is General Manager of Respiratory Care…
The Anesthesia Patient Safety Foundation (APSF) is pleased to report that it continues to attract outstanding applications for funding. The educational focus of APSF includes innovative methods of education and…
Guidelines for Grant Applications Scheduled to Be Funded January 1, 2007 The Anesthesia Patient Safety Foundation (APSF) Grant Program supports research directed toward enhancing anesthesia patient safety. Its major objective…
Nearly 1,500 scientific papers were presented at the 2005 American Society of Anesthesiologists Annual Meeting in Atlanta, Georgia. Important studies relating to patient safety were discussed in many of the…
Patient safety again was a prominent theme in the exhibit hall at the American Society of Anesthesiologists Annual Meeting October 22-26, even with the hurried translocation from hurricane-ravaged New Orleans…
The following are the minutes of a roundtable discussion held in Louisville, KY, on June 11, 2005, chaired by Scott Robinson, MD, and Kushagra Katariya, MD. Also participating were Dan…
Reprinted with permission of Texas Medical Liability Trust. The following scenario is a synopsis of the anesthesiologist’s worst nightmare: can’t intubate/can’t ventilate. This ongoing concern in anesthesiology is being revisited…
Placing a label on an otherwise unmarked syringe containing a drug intended for intravenous use would seem an uncontroversial contribution to patient safety. Yet 20 years after the original specification…
Editor’s Note: Although Dr. Wright may have later determined the manufacturer of the product in question, the Editors subsequently located at least 2 additional reports of circuit obstruction by unwrapped…
To the Editor The Fall 2005 issue of the Anesthesia Patient Safety Foundation (APSF) Newsletter includes the article “DepoDur™: A New Drug Formulation With Unique Safety Considerations.” It is disclosed…
To the Editor We read with interest, and much dismay, the letter by Dr. Thomas Parker, Jr., regarding labor epidurals in the summer 2005 issue of the APSF Newsletter. Dr….
To the Editor Bravo to Dr. Terring W. Herionimus, III, MD, FACA, FCCP, for his excellent letter published in the Spring 2005 APSF Newsletter. In his discussion of the tragic…
To the Editor We strongly support Overdyk’s communication1 about the many patients daily at risk of respiratory depression, and would like to elaborate on 3 issues he raised in order…
To the Editor I would like to comment on 2 articles in the fall APSF Newsletter, “Complications of Cervical Epidural Blocks Attract Insurance Company Attention” and “DepoDur™: A New Drug…
To the Editor DepoDur™ will certainly find its niche in the acute pain management arena; however, this formulation should be used with extreme caution. Not only did 75% of the…
To the Editor I read with interest the letter in the Fall 2005 issue of the APSF Newsletter from Dr. Okwuone. Corneal abrasions have been the most frequent complication of…
To the Editor We recently had a child in the cardiac catheterization lab experience extensive third-degree burns of a leg due to the forced-air warmer. After analysis of this case,…
To the Editor I appreciate the attention that your newsletter has given to the threats to patient safety that arise from fatigued anesthesia providers. I agree with Dr. Curry’s letter…
To the Editor Dr. Lambert clearly presents the need for commercially prepared appropriately diluted resuscitation medications.1 In the absence of such, some of the concerns that he identifies can be…
The Anesthesia Patient Safety Foundation Newsletter is the official publication of the nonprofit Anesthesia Patient Safety Foundation and is published quarterly at Wilmington, Delaware. Annual contributor status: Individual – $100.00, Corporate – $500.00. This and any additional contributions to the Foundation are tax deductible.
© Copyright, Anesthesia Patient Safety Foundation, 2006.
The opinions expressed in this Newsletter are not necessarily those of the Anesthesia Patient Safety Foundation or its members or board of directors. Validity of opinions presented, drug dosages, accuracy, and completeness of content are not guaranteed by the APSF.
Robert K. Stoelting, MD, President; Jeffrey B. Cooper, PhD, Executive Vice President; George A. Schapiro, Executive Vice President; David M. Gaba, MD, Secretary; Casey D. Blitt, MD, Treasurer; Sorin J. Brull, MD; Robert A. Caplan, MD; Nassib G. Chamoun; Robert C. Morell, MD; Michael A. Olympio, MD; Richard C. Prielipp, MD.
Robert C. Morell, MD, Editor; Sorin J. Brull, MD; Joan Christie, MD; Jan Ehrenwerth, MD; John H. Eichhorn, MD; Regina King; Lorri A. Lee, MD ; Rodney C. Lester, PhD, CRNA; Glenn S. Murphy, MD; Denise O’Brien, BSN, RN; Karen Posner, PhD; Keith Ruskin, MD; Wilson Somerville, PhD; Jeffery Vender, MD.
